Extension of Timetable in relation to Placing

AI SummaryClose X

Oxford BioDynamics Plc has extended the timetable for the settlement of a £250,000 outstanding payment from Vulpes Investment Management, a related party, to October 30, 2026, as part of a previously announced £9.15 million placing. This extension, agreed upon by the company and its advisors, is considered fair and reasonable by the directors not involved in the placing and is not expected to impact the company's financial position or prospects. Vulpes, through its associated funds, is a significant shareholder, holding 6.46% of the company's issued share capital, with a non-executive director having an interest in these holdings.

Disclaimer*

UK 100